Compare FIP & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FIP | LXRX |
|---|---|---|
| Founded | 2021 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 567.5M | 547.4M |
| IPO Year | 2021 | 2000 |
| Metric | FIP | LXRX |
|---|---|---|
| Price | $5.42 | $1.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $11.00 | $4.63 |
| AVG Volume (30 Days) | 1.0M | ★ 2.3M |
| Earning Date | 05-27-2026 | 06-08-2026 |
| Dividend Yield | ★ 2.10% | N/A |
| EPS Growth | N/A | ★ 77.78 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $331,497,000.00 | $49,803,000.00 |
| Revenue This Year | $65.86 | N/A |
| Revenue Next Year | $26.70 | $22.16 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 3.44 | ★ 60.24 |
| 52 Week Low | $3.10 | $0.32 |
| 52 Week High | $7.93 | $1.83 |
| Indicator | FIP | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 41.20 | 66.31 |
| Support Level | $4.06 | $1.08 |
| Resistance Level | $5.45 | $1.83 |
| Average True Range (ATR) | 0.40 | 0.12 |
| MACD | -0.09 | 0.02 |
| Stochastic Oscillator | 9.79 | 84.83 |
FTAI Infrastructure Inc is engaged in five segments; Railroad segment includes five freight railroads and one switching company that provide rail service to certain manufacturing and production facilities, the Jefferson Terminal segment consists of a multi-modal crude oil and refined products terminal and other related assets. Repauno segment consists of a 1,630-acre deep-water port located along the Delaware River with an underground storage cavern, a new multipurpose dock, a rail-to-ship transloading system, and multiple industrial development opportunities. Power and Gas segment is comprised of an equity method investment in Long Ridge, and Sustainability and Energy Transition segment is comprised of Aleon/Gladieux, Clean Planet, and CarbonFree.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.